Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community
University of Pittsburgh · with Horizon Pharma USA, Inc. · NCT02927158
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 300
- US sites recruiting
- 1
- Study start
- August 2016
- Record last updated
- March 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is designed to utilize whole exome and whole genome sequencing techniques to identify underlying genetic causes for undiagnosed disorders in the Plain Communities, and to do population genetic studies looking at genetic drift and founder mutations in this unique population.
Conditions: Undiagnosed Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Any person of Amish or Mennonite descent
Exclusion Criteria
- Individuals who are not of Amish or Mennonite descent
Recruiting US locations
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, PA 15224
Site contact: Jennifer Baker, MA · 412-692-6378 · jennifer.baker@chp.edu
Study contacts (from the official record)
- Cate Walsh Vockley, MS, LCGC · 412-692-7349 · catherine.walshvockley@chp.edu
- Jenifer Baker, MA · 412-6926378 · jennifer.baker@chp.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only